CoChat

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort

Open access
St John-Williams, Lisa, Blach, Colette, Toledo, Jon B., Rotroff, Daniel M., Kim, Sungeun, Klavins, Kristaps, Baillie, Rebecca, Han, Xianlin, Mahmoudiandehkordi, Siamak, Jack, John, Massaro, Tyler J., Lucas, Joseph E., Louie, Gregory, Motsinger-Reif, Alison A., Risacher, Shannon L., Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium, Saykin, Andrew J., Kastenmüller, Gabi, Arnold, Matthias, Koal, Therese, Moseley, M. Arthur, Mangravite, Lara M., Peters, Mette A., Tenenbaum, Jessica D., Thompson, J. Will, Kaddurah-Daouk, Rima · 2017 · Scientific Data
Cited by 71

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD) is the most common neurodegenerative disease presenting major health and economic challenges that continue to grow. Mechanisms of disease are poorly understood but significant data point to metabolic defects that might contribute to disease pathogenesis. The Alzheimer Disease Metabolomics Consortium (ADMC) in partnership with Alzheimer Disease Neuroimaging Initiative (ADNI) is creating a comprehensive biochemical database for AD. Using targeted and non- targeted metabolomics and lipidomics platforms we are mapping metabolic pathway and network failures across the trajectory of disease. In this report we present quantitative metabolomics data generated on serum from 199 control, 356 mild cognitive impairment and 175 AD subjects enrolled in ADNI1 using AbsoluteIDQ-p180 platform, along with the pipeline for data preprocessing and medication classification for confound correction. The dataset presented here is the first of eight metabolomics datasets being generated for broad biochemical investigation of the AD metabolome. We expect that these collective metabolomics datasets will provide valuable resources for researchers to identify novel molecular mechanisms contributing to AD pathogenesis and disease phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sdata.2017.140

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 71

Metadata

Authors
St John-Williams, L., Blach, C., Toledo, J. B., Rotroff, D. M., Kim, S., Klavins, K., Baillie, R., Han, X., Mahmoudiandehkordi, S., Jack, J., Massaro, T. J., Lucas, J. E., Louie, G., Motsinger-Reif, A. A., Risacher, S. L., Initiative, A. D. N., Alzheimer’s Disease Metabolomics Consortium, Saykin, A. J., Kastenmüller, G., Arnold, M., Koal, T., Moseley, M. A., Mangravite, L. M., Peters, M. A., Tenenbaum, J. D., Thompson, J. W., & Kaddurah-Daouk, R.
Venue
Scientific Data
Published
2017-10-17
Volume
4
Issue
1
Pages
170140-170140
ISSN
2052-4463 (ISSN-L)
OpenAlex
W2766580836
Cited by
71
References
5
Type
data paper
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. https://app.cochat.ai/papers/10.1038/sdata.2017.140
The paper
St John-Williams, L., Blach, C., Toledo, J. B., Rotroff, D. M., Kim, S., Klavins, K., Baillie, R., Han, X., Mahmoudiandehkordi, S., Jack, J., Massaro, T. J., Lucas, J. E., Louie, G., Motsinger-Reif, A. A., Risacher, S. L., Initiative, A. D. N., Alzheimer’s Disease Metabolomics Consortium, Saykin, A. J., Kastenmüller, G., . . . Kaddurah-Daouk, R. (2017). Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Scientific Data. https://doi.org/10.1038/sdata.2017.140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.